Guangdong Marubi Biotechnology Co (603983) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.25 Million ≈ $6.33 Million USD) by net assets (CN¥3.39 Billion ≈ $496.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangdong Marubi Biotechnology Co - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Guangdong Marubi Biotechnology Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603983 liabilities breakdown for a breakdown of total debt and financial obligations.
Guangdong Marubi Biotechnology Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Marubi Biotechnology Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ShanXi Coking Co Ltd
SHG:600740
|
0.010x |
|
Xinjiang Communications Construction Group Co Ltd Class A
SHE:002941
|
0.086x |
|
Jiangsu Bojun Industrial Technology Co. Ltd
SHE:300926
|
0.021x |
|
Arteche Lantegi Elkartea SA
MC:ART
|
0.249x |
|
SoftwareONE Holding AG
SW:SWON
|
0.171x |
|
Global Brands Manufacture Ltd
TW:6191
|
0.059x |
|
JM Financial Limited
NSE:JMFINANCIL
|
-0.029x |
|
Shenzhen Click Technology Co Ltd
SHE:002782
|
0.103x |
Annual Cash Flow Conversion Efficiency for Guangdong Marubi Biotechnology Co (2011–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Marubi Biotechnology Co from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Guangdong Marubi Biotechnology Co stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.45 Billion ≈ $504.33 Million |
CN¥300.53 Million ≈ $43.98 Million |
0.087x | -11.81% |
| 2023-12-31 | CN¥3.42 Billion ≈ $500.24 Million |
CN¥338.02 Million ≈ $49.46 Million |
0.099x | +564.00% |
| 2022-12-31 | CN¥3.25 Billion ≈ $475.96 Million |
CN¥48.44 Million ≈ $7.09 Million |
0.015x | +728.75% |
| 2021-12-31 | CN¥3.16 Billion ≈ $462.18 Million |
CN¥-7.48 Million ≈ $-1.09 Million |
-0.002x | -101.96% |
| 2020-12-31 | CN¥3.00 Billion ≈ $439.09 Million |
CN¥362.35 Million ≈ $53.02 Million |
0.121x | -30.74% |
| 2019-12-31 | CN¥2.67 Billion ≈ $390.69 Million |
CN¥465.53 Million ≈ $68.12 Million |
0.174x | -53.37% |
| 2018-12-31 | CN¥1.38 Billion ≈ $202.21 Million |
CN¥516.69 Million ≈ $75.61 Million |
0.374x | +0.77% |
| 2017-12-31 | CN¥959.96 Million ≈ $140.47 Million |
CN¥356.20 Million ≈ $52.12 Million |
0.371x | +44.03% |
| 2016-12-31 | CN¥828.09 Million ≈ $121.18 Million |
CN¥213.33 Million ≈ $31.22 Million |
0.258x | -32.96% |
| 2015-12-31 | CN¥715.92 Million ≈ $104.76 Million |
CN¥275.11 Million ≈ $40.26 Million |
0.384x | -38.26% |
| 2014-12-31 | CN¥604.48 Million ≈ $88.45 Million |
CN¥376.24 Million ≈ $55.06 Million |
0.622x | -13.40% |
| 2013-12-31 | CN¥453.11 Million ≈ $66.30 Million |
CN¥325.67 Million ≈ $47.66 Million |
0.719x | -25.79% |
| 2012-12-31 | CN¥234.87 Million ≈ $34.37 Million |
CN¥227.49 Million ≈ $33.29 Million |
0.969x | -46.78% |
| 2011-12-31 | CN¥148.02 Million ≈ $21.66 Million |
CN¥269.39 Million ≈ $39.42 Million |
1.820x | -- |
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Haruji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.